nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanidine—SLC22A2—Cytarabine—lymphatic system cancer	0.249	0.343	CbGbCtD
Guanidine—SLC22A1—Cytarabine—lymphatic system cancer	0.217	0.298	CbGbCtD
Guanidine—SLC22A3—Vincristine—lymphatic system cancer	0.2	0.275	CbGbCtD
Guanidine—SLC22A8—Methotrexate—lymphatic system cancer	0.0614	0.0844	CbGbCtD
Guanidine—Azotaemia—Mechlorethamine—lymphatic system cancer	0.0161	0.0636	CcSEcCtD
Guanidine—Petechiae—Mechlorethamine—lymphatic system cancer	0.0104	0.0412	CcSEcCtD
Guanidine—GAMT—Podofilox—Teniposide—lymphatic system cancer	0.0101	0.526	CbGdCrCtD
Guanidine—Azotaemia—Carmustine—lymphatic system cancer	0.00668	0.0264	CcSEcCtD
Guanidine—Azotaemia—Vincristine—lymphatic system cancer	0.00638	0.0252	CcSEcCtD
Guanidine—Abdominal cramps—Vincristine—lymphatic system cancer	0.00503	0.0199	CcSEcCtD
Guanidine—Liver function test abnormal—Teniposide—lymphatic system cancer	0.00424	0.0167	CcSEcCtD
Guanidine—GAMT—Vinblastine—Vincristine—lymphatic system cancer	0.00415	0.215	CbGdCrCtD
Guanidine—Petechiae—Mitoxantrone—lymphatic system cancer	0.00402	0.0159	CcSEcCtD
Guanidine—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.00373	0.0147	CcSEcCtD
Guanidine—Sweating—Teniposide—lymphatic system cancer	0.00339	0.0134	CcSEcCtD
Guanidine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00336	0.0133	CcSEcCtD
Guanidine—Azotaemia—Methotrexate—lymphatic system cancer	0.00309	0.0122	CcSEcCtD
Guanidine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.003	0.0118	CcSEcCtD
Guanidine—Ecchymosis—Mitoxantrone—lymphatic system cancer	0.00299	0.0118	CcSEcCtD
Guanidine—Flushing—Teniposide—lymphatic system cancer	0.00295	0.0116	CcSEcCtD
Guanidine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00292	0.0115	CcSEcCtD
Guanidine—Eruption—Methotrexate—lymphatic system cancer	0.00268	0.0106	CcSEcCtD
Guanidine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00266	0.0105	CcSEcCtD
Guanidine—Folliculitis—Methotrexate—lymphatic system cancer	0.00262	0.0103	CcSEcCtD
Guanidine—GAMT—Azacitidine—Fludarabine—lymphatic system cancer	0.00258	0.133	CbGdCrCtD
Guanidine—Anaemia—Teniposide—lymphatic system cancer	0.00256	0.0101	CcSEcCtD
Guanidine—Leukopenia—Teniposide—lymphatic system cancer	0.00248	0.00977	CcSEcCtD
Guanidine—GAMT—Azacitidine—Cytarabine—lymphatic system cancer	0.00243	0.126	CbGdCrCtD
Guanidine—Ataxia—Carmustine—lymphatic system cancer	0.00243	0.00959	CcSEcCtD
Guanidine—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00239	0.00941	CcSEcCtD
Guanidine—Ataxia—Vincristine—lymphatic system cancer	0.00232	0.00915	CcSEcCtD
Guanidine—Confusional state—Teniposide—lymphatic system cancer	0.00228	0.00898	CcSEcCtD
Guanidine—Anaemia—Fludarabine—lymphatic system cancer	0.00225	0.00887	CcSEcCtD
Guanidine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00221	0.00872	CcSEcCtD
Guanidine—Tachycardia—Teniposide—lymphatic system cancer	0.0022	0.00869	CcSEcCtD
Guanidine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00218	0.00861	CcSEcCtD
Guanidine—Leukopenia—Fludarabine—lymphatic system cancer	0.00218	0.00859	CcSEcCtD
Guanidine—Anorexia—Teniposide—lymphatic system cancer	0.00215	0.00849	CcSEcCtD
Guanidine—Hypotension—Teniposide—lymphatic system cancer	0.00211	0.00832	CcSEcCtD
Guanidine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0021	0.00827	CcSEcCtD
Guanidine—Petechiae—Methotrexate—lymphatic system cancer	0.002	0.00791	CcSEcCtD
Guanidine—Confusional state—Fludarabine—lymphatic system cancer	0.002	0.00789	CcSEcCtD
Guanidine—Decreased appetite—Teniposide—lymphatic system cancer	0.00196	0.00774	CcSEcCtD
Guanidine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00194	0.00766	CcSEcCtD
Guanidine—Rash—Mechlorethamine—lymphatic system cancer	0.00193	0.00762	CcSEcCtD
Guanidine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00193	0.00761	CcSEcCtD
Guanidine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00192	0.00757	CcSEcCtD
Guanidine—Flushing—Bleomycin—lymphatic system cancer	0.0019	0.0075	CcSEcCtD
Guanidine—Anorexia—Fludarabine—lymphatic system cancer	0.00189	0.00746	CcSEcCtD
Guanidine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00186	0.00734	CcSEcCtD
Guanidine—Sweating—Vincristine—lymphatic system cancer	0.00182	0.00719	CcSEcCtD
Guanidine—Nausea—Mechlorethamine—lymphatic system cancer	0.00182	0.00718	CcSEcCtD
Guanidine—Body temperature increased—Teniposide—lymphatic system cancer	0.00178	0.00704	CcSEcCtD
Guanidine—Abdominal pain—Teniposide—lymphatic system cancer	0.00178	0.00704	CcSEcCtD
Guanidine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00178	0.00703	CcSEcCtD
Guanidine—Hallucination—Carmustine—lymphatic system cancer	0.00178	0.00702	CcSEcCtD
Guanidine—Sweating—Mitoxantrone—lymphatic system cancer	0.00177	0.007	CcSEcCtD
Guanidine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00172	0.00681	CcSEcCtD
Guanidine—Hallucination—Vincristine—lymphatic system cancer	0.0017	0.0067	CcSEcCtD
Guanidine—Flushing—Carmustine—lymphatic system cancer	0.00166	0.00654	CcSEcCtD
Guanidine—Anaemia—Bleomycin—lymphatic system cancer	0.00165	0.0065	CcSEcCtD
Guanidine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00163	0.00645	CcSEcCtD
Guanidine—Leukopenia—Bleomycin—lymphatic system cancer	0.0016	0.0063	CcSEcCtD
Guanidine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00157	0.00619	CcSEcCtD
Guanidine—Diarrhoea—Teniposide—lymphatic system cancer	0.00154	0.00609	CcSEcCtD
Guanidine—Ecchymosis—Methotrexate—lymphatic system cancer	0.00149	0.00588	CcSEcCtD
Guanidine—Confusional state—Bleomycin—lymphatic system cancer	0.00147	0.00579	CcSEcCtD
Guanidine—Tremor—Carmustine—lymphatic system cancer	0.00146	0.00575	CcSEcCtD
Guanidine—Anaemia—Carmustine—lymphatic system cancer	0.00144	0.00567	CcSEcCtD
Guanidine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00142	0.00562	CcSEcCtD
Guanidine—Rash—Teniposide—lymphatic system cancer	0.00142	0.00562	CcSEcCtD
Guanidine—Dermatitis—Teniposide—lymphatic system cancer	0.00142	0.00561	CcSEcCtD
Guanidine—Leukopenia—Carmustine—lymphatic system cancer	0.00139	0.0055	CcSEcCtD
Guanidine—Anorexia—Bleomycin—lymphatic system cancer	0.00139	0.00547	CcSEcCtD
Guanidine—Anaemia—Vincristine—lymphatic system cancer	0.00137	0.00542	CcSEcCtD
Guanidine—Hypotension—Bleomycin—lymphatic system cancer	0.00136	0.00536	CcSEcCtD
Guanidine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00136	0.00536	CcSEcCtD
Guanidine—Nausea—Teniposide—lymphatic system cancer	0.00134	0.00529	CcSEcCtD
Guanidine—Anaemia—Mitoxantrone—lymphatic system cancer	0.00134	0.00527	CcSEcCtD
Guanidine—Leukopenia—Vincristine—lymphatic system cancer	0.00133	0.00525	CcSEcCtD
Guanidine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00131	0.00515	CcSEcCtD
Guanidine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00129	0.00511	CcSEcCtD
Guanidine—Confusional state—Carmustine—lymphatic system cancer	0.00128	0.00505	CcSEcCtD
Guanidine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00126	0.00499	CcSEcCtD
Guanidine—Rash—Fludarabine—lymphatic system cancer	0.00125	0.00494	CcSEcCtD
Guanidine—Dermatitis—Fludarabine—lymphatic system cancer	0.00125	0.00493	CcSEcCtD
Guanidine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00124	0.00491	CcSEcCtD
Guanidine—Tachycardia—Carmustine—lymphatic system cancer	0.00124	0.00489	CcSEcCtD
Guanidine—Anorexia—Carmustine—lymphatic system cancer	0.00121	0.00478	CcSEcCtD
Guanidine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0012	0.00473	CcSEcCtD
Guanidine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00119	0.0047	CcSEcCtD
Guanidine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00119	0.00468	CcSEcCtD
Guanidine—Hypotension—Carmustine—lymphatic system cancer	0.00119	0.00468	CcSEcCtD
Guanidine—Nausea—Fludarabine—lymphatic system cancer	0.00118	0.00465	CcSEcCtD
Guanidine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00117	0.00462	CcSEcCtD
Guanidine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00116	0.00456	CcSEcCtD
Guanidine—Anorexia—Vincristine—lymphatic system cancer	0.00116	0.00456	CcSEcCtD
Guanidine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00115	0.00455	CcSEcCtD
Guanidine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00115	0.00454	CcSEcCtD
Guanidine—Irritability—Methotrexate—lymphatic system cancer	0.00114	0.00451	CcSEcCtD
Guanidine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00114	0.0045	CcSEcCtD
Guanidine—Paraesthesia—Carmustine—lymphatic system cancer	0.00114	0.0045	CcSEcCtD
Guanidine—Mood swings—Methotrexate—lymphatic system cancer	0.00113	0.00447	CcSEcCtD
Guanidine—Hypotension—Vincristine—lymphatic system cancer	0.00113	0.00447	CcSEcCtD
Guanidine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00113	0.00444	CcSEcCtD
Guanidine—Ataxia—Methotrexate—lymphatic system cancer	0.00113	0.00444	CcSEcCtD
Guanidine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.0011	0.00436	CcSEcCtD
Guanidine—Decreased appetite—Carmustine—lymphatic system cancer	0.0011	0.00436	CcSEcCtD
Guanidine—Hypotension—Mitoxantrone—lymphatic system cancer	0.0011	0.00435	CcSEcCtD
Guanidine—Paraesthesia—Vincristine—lymphatic system cancer	0.00109	0.00429	CcSEcCtD
Guanidine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00106	0.00418	CcSEcCtD
Guanidine—Decreased appetite—Vincristine—lymphatic system cancer	0.00105	0.00416	CcSEcCtD
Guanidine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00105	0.00413	CcSEcCtD
Guanidine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00103	0.00405	CcSEcCtD
Guanidine—Abdominal pain—Carmustine—lymphatic system cancer	0.001	0.00396	CcSEcCtD
Guanidine—Body temperature increased—Carmustine—lymphatic system cancer	0.001	0.00396	CcSEcCtD
Guanidine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000973	0.00384	CcSEcCtD
Guanidine—Body temperature increased—Vincristine—lymphatic system cancer	0.000958	0.00378	CcSEcCtD
Guanidine—Abdominal pain—Vincristine—lymphatic system cancer	0.000958	0.00378	CcSEcCtD
Guanidine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000933	0.00368	CcSEcCtD
Guanidine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000933	0.00368	CcSEcCtD
Guanidine—Rash—Bleomycin—lymphatic system cancer	0.000917	0.00362	CcSEcCtD
Guanidine—Dermatitis—Bleomycin—lymphatic system cancer	0.000916	0.00362	CcSEcCtD
Guanidine—Sweating—Methotrexate—lymphatic system cancer	0.000884	0.00349	CcSEcCtD
Guanidine—Diarrhoea—Carmustine—lymphatic system cancer	0.000869	0.00343	CcSEcCtD
Guanidine—Nausea—Bleomycin—lymphatic system cancer	0.000864	0.00341	CcSEcCtD
Guanidine—Dizziness—Carmustine—lymphatic system cancer	0.00084	0.00331	CcSEcCtD
Guanidine—Diarrhoea—Vincristine—lymphatic system cancer	0.000829	0.00327	CcSEcCtD
Guanidine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000808	0.00319	CcSEcCtD
Guanidine—Dizziness—Vincristine—lymphatic system cancer	0.000802	0.00316	CcSEcCtD
Guanidine—Rash—Carmustine—lymphatic system cancer	0.000801	0.00316	CcSEcCtD
Guanidine—Dermatitis—Carmustine—lymphatic system cancer	0.0008	0.00316	CcSEcCtD
Guanidine—Rash—Vincristine—lymphatic system cancer	0.000764	0.00302	CcSEcCtD
Guanidine—Dermatitis—Vincristine—lymphatic system cancer	0.000764	0.00301	CcSEcCtD
Guanidine—Nausea—Carmustine—lymphatic system cancer	0.000754	0.00298	CcSEcCtD
Guanidine—Rash—Mitoxantrone—lymphatic system cancer	0.000744	0.00294	CcSEcCtD
Guanidine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000744	0.00293	CcSEcCtD
Guanidine—Nausea—Vincristine—lymphatic system cancer	0.00072	0.00284	CcSEcCtD
Guanidine—Nausea—Mitoxantrone—lymphatic system cancer	0.000701	0.00277	CcSEcCtD
Guanidine—Anaemia—Methotrexate—lymphatic system cancer	0.000666	0.00263	CcSEcCtD
Guanidine—Leukopenia—Methotrexate—lymphatic system cancer	0.000645	0.00255	CcSEcCtD
Guanidine—Confusional state—Methotrexate—lymphatic system cancer	0.000593	0.00234	CcSEcCtD
Guanidine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000576	0.00227	CcSEcCtD
Guanidine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000569	0.00224	CcSEcCtD
Guanidine—Anorexia—Methotrexate—lymphatic system cancer	0.000561	0.00221	CcSEcCtD
Guanidine—Hypotension—Methotrexate—lymphatic system cancer	0.00055	0.00217	CcSEcCtD
Guanidine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000528	0.00208	CcSEcCtD
Guanidine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000511	0.00202	CcSEcCtD
Guanidine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000485	0.00191	CcSEcCtD
Guanidine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000465	0.00183	CcSEcCtD
Guanidine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000465	0.00183	CcSEcCtD
Guanidine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000402	0.00159	CcSEcCtD
Guanidine—Dizziness—Methotrexate—lymphatic system cancer	0.000389	0.00153	CcSEcCtD
Guanidine—Rash—Methotrexate—lymphatic system cancer	0.000371	0.00146	CcSEcCtD
Guanidine—Dermatitis—Methotrexate—lymphatic system cancer	0.000371	0.00146	CcSEcCtD
Guanidine—Nausea—Methotrexate—lymphatic system cancer	0.000349	0.00138	CcSEcCtD
